CardioDynamics’s impedance cardiography (ICG) products enable Global Research Services (GRS) to provide expanded biometrics and data management services in support of clinical trials. The combined strengths of both the companies will allow biotechnology, pharmaceutical, and device companies and clinical research sites to obtain the benefits of enhanced cardiac safety monitoring in Phase I through IV clinical trials.
Sandra Garrett, executive chair, GRS, said: “This technology, coupled with our Oracle Clinical data management capabilities clearly elevates the capability of cardiac safety monitoring and evaluation in research settings.”